Annapolis, MD—The Plasma Protein Therapeutics Association (PPTA) recently launched the Cross Donation Check System (CDCS), a new electronic database designed to assist plasma centers in checking donors more efficiently and effectively.
(20th January 2015 – Brussels) – AESGP, EFPIA, EGA, and PPTA are pleased to announce today’s release of the joint principles for “Communication of information on quality and manufacturing potential supply disruption”. This document forms part of the industry response to the EMA (European Medicines Agency) call for voluntary and proactive action, to provide European patients with continuous access to medicines.
Annapolis, MD--The second annual International Plasma Awareness Week (IPAW) will be celebrated October 12-18. A joint initiative of the Plasma Protein Therapeutics Association (PPTA) and its member companies, IPAW is designed to:
April 17, 2014–The Plasma Protein Therapeutics Association (PPTA) recognizes World Hemophilia Day, an annual international event sponsored by the World Federation for Hemophilia (WFH) that seeks to raise awareness of people living with inherited bleeding disorders.
ANNAPOLIS, MD—The Plasma Protein Therapeutics Association (PPTA) has awarded Plazmaferezis Állomás Kft (PFÁ), a member operating within the Kedrion group of companies, with International Quality Plasma Program (IQPP) certification for its plasma collection centers in Hungary; two in Budapest and one in Debrecen. The three centers are the first in the country to become IQPP certified.
Dear PPTA Stakeholders:
I would like to provide a status report on implementation of PPTA’s European Data Program.
As you know, PPTA launched the program in November 2013 starting with the reporting of Recombinant Factor VIII data. We committed as well to soon begin reporting data on a more complete set of plasma protein therapies. Today we are able to honor that commitment. Please click here to access the data.
Dear PPTA Stakeholders:
PPTA is pleased to announce the addition of public reporting of monthly distribution data for plasma protein therapies to its Web site, www.pptaglobal.org.1 This data is intended to provide patients and other stakeholders, as well as manufacturers and regulators, with information regarding the availability of these critical, often life-sustaining, therapies.
Annapolis, MD—The Plasma Protein Therapeutics Association (PPTA) and its member companies, the major collectors of human plasma and manufacturers of plasma protein therapies will hold their annual PPTA Business Forum in Denver on October 13. The meeting coincides with a kickoff celebration for International Plasma Awareness Week (IPAW), October 13-20, a new global awareness event designed to:
Annapolis, MD—The Plasma Protein Therapeutics Association (PPTA) and its member companies are sponsoring International Plasma Awareness Week, October 13-20, designed to:
Brussels, Belgium—The Plasma Protein Therapeutics Association (PPTA), together with Pharmig and IG Plasma are sponsoring a workshop as part of International Plasma Awareness Week, October 13-20. This event is a joint initiative of PPTA and its member companies designed to:
